Course Provider
Alma Institute is an Oregon-based nonprofit training program founded by Rebecca Martinez to strengthen and diversify the network of licensed psilocybin facilitators by centering people from marginalized and low-income communities. One of only two nonprofits approved to provide OHA psilocybin facilitator training in Oregon, Alma integrates trauma-informed, culturally responsive pedagogy with the full Oregon Psilocybin Services licensing curriculum.
Linked Courses
6
Active Listings
6
Primary Formats
Hybrid, Self-paced
Programs linked directly to this provider in the Blossom course dataset.
By Alma Institute
Courses on ketamine-assisted psychotherapy for clinicians and other learners exploring clinical and integration approaches to ketamine use in therapeutic settings.
Next cohort: Sep 1, 2026
By Alma Institute
Ketamine-assisted therapy courses focused on clinical and practice-related skills for working with ketamine therapy. The page groups courses and related training topics connected to ketamine-assisted care.
Next cohort: Sep 1, 2026
By Alma Institute
Psychotherapy skill topic focused on courses related to psychedelic therapy, integration, facilitation, ethics, and trauma-informed care. It is used to group courses that cover psychotherapy-adjacent practice and clinical topics.
Next cohort: Sep 1, 2026
By Alma Institute
The Alma Institute’s Facilitator Training preps you to be an Oregon-certified psilocybin guide. You’ll learn client vetting, session prep, psilocybin dosing, aftercare, and referral skills.
Next cohort: Dec 1, 2026
By Alma Institute
Psychedelic-assisted psychotherapy courses covering clinical training, integration, and related therapeutic skills. Listings on this page vary by provider, format, and audience.
Next cohort: Dec 1, 2026
By Alma Institute
Integration courses focused on making sense of psychedelic experiences and turning insights into practical next steps. The directory page groups courses that cover integration as a clinical, facilitation, or personal-development skill.
Next cohort: Sep 1, 2026
Self-paced access